@FierceMedDev: ICYMI yesterday: FierceMedicalDevices' 2013 Fierce 15. Feature | Follow @FierceMedDev
> GE Healthcare ($GE) is warning customers that some of its anesthesia delivery systems can malfunction, leading to higher-than-expected dosing. News
> MDxHealth plans to expand its PredictMDx brain tumor test in the U.S. now that the diagnostic has been included in the guidelines of the National Comprehensive Cancer Network. More
> RTI ($RTIX) has signed a deal with Medtronic ($MDT) to distribute allograft implants for use in spinal surgeries. Announcement
> Australia's Osprey Medical is raising about $13.4 million through a private placement to support its FDA-cleared interventional cardiology device. Release
> Device incubator Inceptus Medical has raised $4.7 million to launch its first company, the cardiovascular-focused Inari Medical. Item
Biotech News
@FierceBiotech: ICYMI yesterday: The top Phase III R&D setbacks of 2013. Feature | Follow @FierceBiotech
@JohnCFierce: Third Rock startup banks $20M to fuel next leg of CNS drug development journey. News | Follow @JohnCFierce
@DamianFierce: St. Jude boosts profits as job cuts, M&A pay off. Article | Follow @DamianFierce
@EmilyMFierce: Georgetown University Medical Center researchers find a vegetable-based compound that protects against side effects of radiation therapy. Article from FierceBiotech Research | Follow @EmilyMFierce
> Is Eli Lilly about to start cutting its blockbuster R&D budget? More
> MedImmune leads $12.5M round for new drug aimed at big chemo market. Article
> Sanofi, Regeneron take the lead in blockbuster PhIII race of PCSK9 drugs. Story
Pharma News
@FiercePharma: Top news online yesterday: J&J hikes earnings forecast on pharma's superhero sales flight. Story | Follow @FiercePharma
@EricPFierce: MHRA says it also took action against Wockhardt contractor Nestor in U.K. as part of recent action. Article from FiercePharmaManufacturing | Follow @EricPFierce
@CarlyHFierce: Look out, Vivus--Eisai to double Belviq sales force by December 2013. Release | Follow @CarlyHFierce
> Sanofi invests in Fabrazyme production as sales soar. Report
> Teva halts Israeli layoff plans amid pressure from labor, government. Article
> Telegraph: GlaxoSmithKline's ex-China chief barred from leaving country. Story
Biomarkers News
> Biomarker differentiates ADHD subtypes, offers clues for treatment. Article
> Amgen taps KineMed for Alzheimer's biomarkers. Report
> Skin may conceal a viable Parkinson's biomarker. Story
Drug Delivery News
@MichaelGFierce: AstraZeneca teams with Taris to research bladder cancer delivery device. Story | Follow @MichaelGFierce
> Mini-pancreas grown from stem cells has implications for future insulin delivery. More
> Cell membrane models 'written' on graphene provide drug-delivery model. Item
> Study: Synthetic RNA conjugates target, silence bacteria's genetic material. Article
> Nanoparticle hydrogel heats up to release drugs in active cartilage. Story
Diagnostics News
@MarkHFierce: Smith & Nephew will handle U.S. distribution of a women's care diagnostic device developed by Femasys. Story | Follow @MarkHFierce
> Applied Proteomics to develop pancreatic and colon cancer Dx with German research institute. More
> Quest preemptively sues Myriad to ensure new BRCA test avoids patent violation. Report
> CardioDx's proposed $86.2M IPO will aid marketing and insurance coverage efforts. Story
> New blood test screens for irritable bowel syndrome. Article
> Mount Sinai's Icahn School of Medicine jumps into Dx, drug development. Item